Mark Behlke

10PUBLICATIONS
80CO-AUTHORS
Software quality, processes and metricsMedical molecular engineering of nucleic acids and proteinsMolecular medicineHaematologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 11, 2026
UNCOVERseq enables sensitive and controlled gene editing off-target nomination across CRISPR-Cas modalities and systems.

|Jul 20, 2021
Author Correction: AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines.

Liyang Zhang, John A Zuris, Ramya Viswanathan

|Jun 24, 2021
AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines.

Liyang Zhang, John A Zuris, Ramya Viswanathan

|May 31, 2021
Sequence-dependent inhibition of cGAS and TLR9 DNA sensing by 2'-O-methyl gapmer oligonucleotides.

Roxane Valentin, Christophe Wong, Arwaf S Alharbi

|Mar 19, 2021
Gene replacement of α-globin with β-globin restores hemoglobin balance in β-thalassemia-derived hematopoietic stem and progenitor cells.

M Kyle Cromer, Joab Camarena, Renata M Martin

|Nov 19, 2020
CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy.

Daniel Rosenblum, Anna Gutkin, Ranit Kedmi

Pageof 2

Frequent Collaborators

6 joint publications

Nicole M Bode

5 joint publications

Christopher A Vakulskas

4 joint publications

Rolf Turk

4 joint publications

Gavin L Kurgan